According to Ken Fisher, the founder and executive chairman of Fisher Investments, American investors continue to undervalue global diversity.

Thermo Fisher Scientific (NYSE:TMO) said it delivered a “strong year” in 2025, closing with what management described as an ...

TMO beats Q4 EPS and revenue estimates, posts 7.1% sales growth, and sees shares rise after results despite margin pressure.

Fisher Investments earned the prestigious Training MVP Award for 2026?the eighth consecutive year Fisher Investments has been recognized for excellence in employee training and development.